Member Info for mazik

Topup time, feel news is at the door. good luck all

Over 100k buys are not small, very few free float dictates the trend

Mozak I agree about confidentiality clause etc...still they never mention about Nuvec patent belongs exclusively to N4p or is it shared with University of Queensland. Please can someone throw some light on this subject I will be grateful , it's over three years now holding and dreaming about n4p...Jack ****e until now mcap under 10m.. share range from 7p to 10p , feel for some holding big amounts in millions...Pied Piper..Nigel can we have new range 20p to 50p....its only a dream...deserve it 4 years have passed and still rubbing Aladdin's lamp for a miracle to happen.

Evotec update due , it's time for Nigel to release more details about the MTA and the pharma behind it..had too much hint from him can we have clarity ? feel its imminent to give this major news to make proper valuation for N4p , present valuation is a joke imo...

8p and its a start of december, new year range into double figures..good luck all

Forfxsake thanks for your feedback..NXF2 phase 1 should rerate nfx, it's time to topup..

Hotchip thanks

WHO has announced for Antigen test worldwide on Sky News for travelling its fits MHC Launch

Well bashed dowm ...when Sar raised funds at 8p per share, thought we were on the way to double figures...all biotech 50% down...

News from Evotec regarding integrated drug discovery with Nuvec in the forefront is all of us waiting for...Nigel could surprise us for Xmas..

oversold for the last few years despite winning contract...strange buy are showing as sell...this should be rerated accordingly... good luck all

Bought when lack of interest by traders...90k shares will do for me

Kane a great summary, this was oversold for 2 years..now we should see gaining ground over 3p next week

Taz agree with u , nfx01 approval in EU and US the share will be rerated..waited long enough

Raaydar last trading update...hope I got it right.

algw market cap should be over £50M /£100M not mere £12m imo, funds managed over a £billion this is overlooked and oversold...

Hall agree with u and Dan, its sad to see long termer left last week after holding for 5 years...

Been with N4P for 4 years, feel we soon will be successful, Acceleration in our understanding of the capabilities of Nuvec(R) following our optimisation work. This has been coupled with our first MTAs which, in turn and together with results elsewhere, led us to review the scope of the recently commenced in vivo work with Evotec pushing some of this work into the second half of this financial year.

"Our strategy remains the same as it always has and that is to generate sufficient proof of concept data with a view to attracting large pharma and biotech partners to enter into collaborations to explore using Nuvec(R) as their chosen delivery system. The issues facing mRNA Covid vaccines in respect of storage and distribution are well known following the Corona virus pandemic. DNA vaccines are more stable than mRNA yet need to use a much higher dose due to the delivery systems currently chosen. Demonstrating suitable efficacy whilst addressing the storage and dosage issues would, we believe, greatly enhance Nuvec(R) as a potential delivery tool for vaccines in the eyes of collaborators.
It all requires Nuvec as vaccine delivery system, covid, malaria, or flu or sars....IMO at MCap of £12 M its a joke..

Leister , wondered what positive impact will pills have over Nuvec....incase n4p is working on oral form than vaccine....Lord knows I might ask by brother who is a consultant at Doncaster...

Afternoon Leister , todays RNS has put the foundation of the commercial future we have in front us, wish we knew who the collaboration is with? Evotec gives me confidence that the data will come sooner than we expect....Nigel noise about China approval is more like certain...GLA